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ABSTRACT
Objectives: The Necessity-Concerns Framework (NCF)
posits that non-adherence to inhaled corticosteroids
(ICS) in asthma is influenced by doubts about the
necessity for ICS and concerns about their potential
adverse effects. This feasibility study examined whether
these beliefs could be changed by briefing asthma
nurse specialists on ways of addressing necessity
beliefs and concerns within consultations.
Design: Pre-post intervention study.
Setting: Secondary care.
Participants: Patients with a diagnosis of moderate to
severe asthma who were prescribed daily ICS were
recruited to either a hospital care group (n=79; 71.0%
female) or intervention group (n=57; 66.7% female).
Intervention: Asthma nurse specialists attended a
1.5-day NCF briefing.
Primary and secondary outcome measures:
Beliefs about ICS (primary outcome) and self-reported
adherence were measured preconsultation and 1 month
postconsultation. Participants also rated their
satisfaction with their consultations immediately after
the consultation. Consultation recordings were coded
to assess intervention delivery.
Results: After the NCF briefing, nurse specialists
elicited and addressed beliefs about medicine more
frequently. The frequency of using the NCF remained
low, for example, open questions eliciting adherence
were used in 0/59 hospital care versus 14/49 (28.6%)
intervention consultations. Doubts about personal
necessity for, and concerns about, ICS were reduced at
1 month postbriefing (p<0.05), but the intervention
was not applied extensively enough to improve
adherence.
Conclusions: The intervention changed nurse
consultations, but not sufficiently enough to fully
address non-adherence or adherence-related ICS
beliefs (necessity and concerns). More effective
techniques are needed to support nurse specialists and
other practitioners to apply the intervention in hospital
asthma review consultations.
Daily inhaled corticosteroids (ICS) are the
most effective method of controlling persist-
ent asthma.1 2 However, up to 60–70% of
asthma patients do not take their ICS as pre-
scribed,3 with non-adherence associated with
increased exacerbations and mortality.4 5
Addressing non-adherence is 1 of the 10 pri-
orities in the Brussels Declaration for redu-
cing the burden of asthma on individuals
and society.1 6 The reasons for non-
adherence are complex, and can include bar-
riers at the healthcare system level, for
example, costs and accessibility of healthcare,
factors associated with the healthcare pro-
vider, for example, whether they have the
necessary knowledge and skills to support
patients to adhere.7 At the individual level,
these barriers can be summarised as a
Strengths and limitations of this study
▪ This study reports on the feasibility of delivering
a theory-based intervention to modify beliefs
within current models of asthma care (asthma
nurse consultations).
▪ Recruitment and retention rates were high for
this type of intervention, reducing potential bias
in the data.
▪ Recordings of the study were used to test inter-
vention fidelity robustly.
▪ As this was a pre–post study, confounders such
as changes in nurses’ consultations or patient
outcomes due to external factors (eg, seasonal
variation, receipt of other training) could not be
controlled.
▪ Sample sizes were relatively small (especially of
nurses), so we cannot be confident that these
findings could extrapolate to nurses and patients
at other clinics.
Chapman SCE, et al. BMJ Open 2015;5:e007354. doi:10.1136/bmjopen-2014-007354 1
Open Access Research
combination of perceptual factors (eg, beliefs about
illness and treatment) and practical factors (eg, capacity
and resources) inﬂuencing motivation and ability to
adhere.8
Studies conducted across long-term conditions includ-
ing asthma have identiﬁed the Necessity-Concerns
Framework (NCF) as a useful method for operationalis-
ing adherence-related beliefs.9–11 The framework posits
that adherence to medication is inﬂuenced by patients’
evaluation of treatment, speciﬁcally judgements of the
personal need for treatment (necessity beliefs) relative
to concerns about the potential negative effects (con-
cerns).11 12 Necessity beliefs are inﬂuenced by illness
beliefs, treatment experiences and expectations; in
symptom-free periods, patients with asthma may ques-
tion their need for ICS (‘no symptoms, no
asthma’).8 9 13 14 Concerns often extend beyond experi-
enced side effects to issues including long-term harm
and dependency.8 Beliefs may diverge from medical evi-
dence but can have a ‘common-sense’ logic, for
example, generalising oral high-dose corticosteroid side
effects to low-dose ICS.13–15 Beliefs about speciﬁc medi-
cines are related to general attitudes to pharmaceuticals
and may be rooted in cultural norms.16 17
The NCF was proposed as an extension of Leventhal’s
Common-Sense Model.18 19 In this model, internal infor-
mation (eg, symptoms) and external information (eg,
medical advice) are potentially threatening to patients
and trigger cognitive and emotional responses in an
attempt to manage the threat and its impact on self
system. These responses can include evaluations (eg, of
the likely consequences of an illness), emotions (eg,
fear), and subsequent coping strategies (eg, healthcare
seeking). The model recognises that these evaluations
and coping strategies are themselves evaluated, and inﬂu-
ence future responses to the threat. The NCF extended
this model by suggesting that in addition to evaluations of
the health threat, perceptions of treatments would also
be important in determining treatment-related
responses, for example, decisions to uptake and adhere
to medication.19
Asthma guidelines recommend patient-centred review,
including adherence, and that treatment beliefs are
addressed.1 20–22 Recent interventions have addressed
treatment beliefs through brief telephone calls from
pharmacists and text messages challenging/reinforcing
medication and illness beliefs,23 24 but it is unclear as to
how to deliver NCF interventions within the existing
models of asthma care.6 8 25
In the UK, asthma review is often undertaken by
asthma nurse specialists.1 In this feasibility study, as part
of a Medical Research Council (MRC) guidance inter-
vention development process,26 we examined the effect
of an NCF brieﬁng covering causes of non-adherence,
and how to identify and address doubts about ICS neces-
sity and concerns on asthma nurse specialists’ consulta-
tions. We evaluated whether it resulted in more focus on
adherence and beliefs about ICS within consultations,
with subsequent improvements in patients’ perceptions
of ICS, adherence and satisfaction with consultations.
We assessed two premises to evaluate the potential efﬁ-
cacy of the intervention: (1) ICS necessity beliefs and
concerns predict adherence in this group and (2) that
nurse specialists would elicit and address ICS beliefs
more frequently postbrieﬁng, indicating ﬁdelity in deliv-
ery of the intervention.
METHOD
Design
This study was a pre–post intervention study. We selected
this pre-post design for the pilot to enable us to
compare nurses’ consultations before and after their
training. This was a pragmatic decision for the pilot
because we did not have the resources to recruit and
randomise nurses to receive the intervention training or
not, which would have required large numbers of nurses
and patients. We used systematic coding of audio record-
ings of consultations and validated questionnaires given
to patients before consultation, immediately after con-
sultation and at 1 month follow-up to assess consulta-
tions. We assessed a prebrieﬁng (referred to as the
‘hospital care’ cohort below) cohort, gave nurse specia-
lists the NCF brieﬁng and then assessed a postbrieﬁng
cohort (the ‘intervention’ group; ﬁgure 1). The study
was approved by the South East Multi-Centre Research
Ethics Committee.
Participants were recruited and followed up between
May 2005 and January 2006. Informed consent was
obtained from patients and nurse specialists before par-
ticipation. For the ﬁrst 3 months, nurse specialists
recruited patients into the hospital care group. Following
this, they received their NCF training (see below), and
then for a further 3 months they recruited additional
patients into the intervention group. Patients completed
four questionnaires (see ﬁgure 1). While waiting for their
appointment, they completed a paper copy of the pre-
consultation ICS Questionnaire and, with the nurse, they
completed the clinical assessment. At the end of their
consultation, they were handed a paper Consultation
Questionnaire with a stamped addressed envelope to
complete and return immediately via post to the research
team, not their nurse. Finally, the ICS Questionnaire and
a stamped addressed envelope were sent to the partici-
pants 1 month after their appointment. If participants
did not return either questionnaire, they were sent a
reminder letter. An individual’s questionnaire responses
were not disclosed to nurse specialists.
Participants
Consecutive patients (intervention n=77; hospital care
n=98) were included if they were aged 18 years or over
and had moderate to severe asthma (as opposed to a
mixed pattern). They were recruited by three experi-
enced asthma nurse specialists (two other nurse specia-
lists withdrew after being recruited into the study) from
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secondary/tertiary centres at Brighton General Hospital,
Guy’s Hospital (London) and the London Chest
Hospital. In both groups, nearly 90% of eligible partici-
pants who were approached by the nurses consented to
take part in the study (intervention: 88.7%; hospital
care: 89.6%).
Intervention
The asthma nurse specialists delivered the intervention
to participants. They were encouraged to target beliefs
about asthma and ICS within their hospital practice and
briefed on the rationale behind this approach over one
full-day and one half-day sessions. We provided NCF
manuals detailing adherence-related beliefs and guide-
lines for eliciting and addressing these beliefs including a
consultation ﬂow chart. The guidelines suggested three
consultation components following National Institute for
Health and Care Excellence (NICE) guidance:22 (1)
communicating a no-blame approach to non-adherence
to facilitate openness; (2) eliciting ICS necessity beliefs
and concerns and (3) addressing doubts about ICS
necessity beliefs and concerns (table 1). Separate manual
pages were provided for reference during consultations.
Measures
The ICS Questionnaire contained two scales:
1. The Beliefs about Medicines Questionnaire Speciﬁc
Asthma version13 measures beliefs about the personal
need for ICS (9 items), for example, My health, at
present, depends on this inhaler, and concerns about the
potential adverse consequences of ICS (12 items), for
example, I sometimes worry about the long term effects of
this inhaler. Statements are endorsed on a Likert-type
scale (range 1=strongly disagree to 5=strongly agree).
We calculated mean item scores (range 1–5) to facili-
tate scale comparisons.27 The Necessity-Concerns
Figure 1 Procedure and questionnaire measures.
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Differential (NCD) was calculated by subtracting the
ICS concerns score from the ICS necessity score
(range −4 to 4). It indicates patients’ overall evalu-
ation of ICS;23 28 29 scores are positive if the per-
ceived need for ICS is high relative to ICS concerns.
The scale is validated for use in asthma samples and
had acceptable reliability at baseline (necessity:
Cronbach’s α=0.83; concerns: Cronbach’s α=0.80).13
2. A brief four-item version of the Medication
Adherence Report Scale (MARS) was used to
measure self-reported adherence to ICS. Each item
(eg, I forget to take my preventer inhaler) was rated on a
Likert-type scale (range 5=never to 1=always).27
Higher total scores (range 4–20) indicate higher
adherence. Items were adapted from the original
MARS to apply to asthma preventer medication, and
one item, I take less than instructed, was omitted from
the scale because it was felt by the research team to
be ambiguous in the context of inhaled asthma treat-
ment. Since previous studies have estimated that
approximately a third of patients may not adhere to
their medication, we compared the lowest third of
participants on the MARS ‘low adherers’ (≤16) with
the highest two-thirds ‘high adherers’ (>16).30 The
MARS has been validated;31 reliability in the current
sample was lower than in previous studies
(Cronbach’s α=0.51). Since this was a new version of
the MARS, and the dichotomisation cut-off had not
been validated, we conducted two additional sensitiv-
ity analyses, ﬁrst, treating the MARS scores as con-
tinuous, and second, using a cut-off to compare
people who reported any non-adherence (MARS
scores <20) to full adherence (MARS scores=20).
The Demographic and Clinical Information
Questionnaire was completed with the asthma nurses.
Patients reported their age, gender, age on leaving full-
time education, ethnicity and marital status. Patients also
reported age of asthma onset, if they smoked currently,
had relatives with asthma or any comorbid illnesses.
The Consultation Questionnaire contained two scales:
1. The Medical Interview Satisfaction Scale (MISS)
assesses patient satisfaction with consultations. We
omitted two items concerning diagnosis (all partici-
pants had an asthma diagnosis), leaving 19 items32 33
rated on a seven-point Likert-type scale (1=very
strongly disagree to 7=very strongly agree). Higher
total scores indicate greater satisfaction (range
19–133, Cronbach’s α=0.76).
2. Satisfaction with intervention skills (MP5) was a new
scale measuring perceptions of skills targeted by the
intervention. It contains ﬁve items (ﬁgure 2), rated
using the seven-point Likert-type scale used in the
Table 1 Intervention components
Intervention Example
Step 1: Provide a ‘no-blame’ space to report any
non-adherence by prefacing the adherence discussion
with an accepting statement
Step 2: Elicit patients’ beliefs about their personal
need for medication including in the absence of
symptoms
AND
Elicit concerns about potential adverse effects of
medication
Step 3: Address concerns or doubts about necessity
using example rationales
Finally, address any other queries including
practical issues
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MISS. Higher total scores (range 5–35) indicate
greater satisfaction with intervention skills. The scale
has not been previously validated. It had good reli-
ability, Cronbach’s α=0.90.
Assessment of fidelity
Consultations were audio recorded and transcribed. Two
independent researchers, blind to whether consultations
were prebrieﬁng or postbrieﬁng, rated transcriptions for
intervention skills using a predeﬁned schedule. For
example, we assessed eliciting ICS concerns using Did the
nurse elicit the patient’s concerns about the medication? scored
0=‘No’; 1=‘Asked indirectly’; 2=‘Yes—asked directly’.
Responses were collapsed into those where both raters
stated that the behaviour was unambiguously present,
for example, coded ‘Yes—asked directly’. Byrt’s preva-
lence and bias-adjusted κ (PABAK) was used to calculate
agreement between raters, in addition to Cohen’s κ,
which is adversely affected when an outcome has low
prevalence.34 Inter-rater agreement was adequate-good
for eliciting concerns (κ=0.76, PABAK=0.80), asking
about adherence using a no-blame frame (κ=0.38,
PABAK=0.58), addressing all concerns (κ=0.53,
PABAK=0.58) and addressing necessity beliefs using the
manual (κ=0.65, PABAK=0.76). Agreement regarding
whether necessity beliefs were elicited was low, κ=0.17
due to the low frequency of elicitations, PABAK=0.68;
however, raters agreed on 72% of interviews. Where one
rater thought that the behaviour was present and
another stated it was not, we erred on the side of
caution when resolving these disagreements by assuming
that the behaviour was not present. For example, where
one rater thought that the nurse had asked about adher-
ence using a no-blame frame, whereas the other rater
did not, we coded this as not being present.
Analysis
Sample size calculation: As this was a feasibility study, we
did not perform a sample size calculation.
Missing data: Mean ICS necessity and concerns values
were calculated. Where four or more values were
missing, the whole scale was treated as missing; where
three or fewer values were missing, the mean of the
completed items was used. Analyses were repeated using
a data set derived using multiple imputation of missing
data. The pattern of results was similar, so original
results are reported here.
Hypothesis testing: Paired samples within group t tests
were used to compare ICS beliefs and adherence at
baseline and follow-up in both groups. Between-groups
independent samples t tests and χ2 were performed to
compare the hospital care with the intervention group
on demographic and clinical variables, nurses’ consult-
ation behaviour and consultation satisfaction; to
compare high and low adherers’ ICS beliefs; and to
compare participants who completed follow-up with
those who did not, on demographic and clinical factors,
baseline beliefs and adherence. Repeated measures ana-
lyses of variance (ANOVAs) were used to test for differ-
ences in changes in beliefs between baseline and
follow-up between groups. Non-parametric correlations
were used to test for associations between beliefs and
self-reported adherence at baseline, when adherence
was treated as a continuous variable.
RESULTS
The intervention and hospital care groups did not differ
signiﬁcantly (all p>0.05) on the demographic and clin-
ical variables (table 2) at baseline. Forty-eight partici-
pants (35.3%) completed the preconsultation ICS
Questionnaire but did not complete the follow-up ICS
Questionnaire (see ﬁgure 1 for details of the ﬂow of par-
ticipants through the study). Participants who did not
continue were younger (mean age=37.37 years,
SD=14.61 years) than those who completed the follow-up
survey (mean age=50.58 years, SD=16.27 years, p<0.001),
less likely to report white ethnicity; 17 (17.9%) white
participants and 10 (58.8%) other ethnicity participants
did not complete the follow-up. There were no other sig-
niﬁcant differences between those who completed and
those who did not.
Intervention effects
Intervention participants had fewer doubts about their
personal need for, and concerns about, ICS at 1 month
follow-up, relative to baseline. The NCD at follow-up
increased signiﬁcantly, indicating increased perceptions
of ICS necessity relative to concerns about ICS postcon-
sultation (see table 3).
In the hospital care group, patients’ necessity and
concern beliefs and NCD score did not signiﬁcantly
change after consultation. Repeated-measures ANOVAs
with the between-subjects factor of group (intervention
or hospital care) and within-subjects factor of time
Figure 2 Intervention-specific skills measure (MP5) items.
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(baseline or follow-up) for ICS necessity, ICS concerns
and the NCD were used to investigate whether changes
in beliefs were larger in the intervention group than in
the hospital care group. There was a signiﬁcant main
effect of time for ICS concerns F(1,82)=4.42, p=0.04 and
the NCD(1,82)=11.48, p<0.01, but not for ICS necessity
F(1,82)=3.26, p=0.07. There were no signiﬁcant main
effects of group for ICS necessity F(1,86)=0.16, p=0.69,
ICS concerns F(1,82)=1.41, p=0.24 or NCD F(1,82)
=0.72, p=0.40. Interaction terms indicated that changes
in beliefs were not signiﬁcantly larger in the interven-
tion group than in the hospital care group for ICS
necessity F(1,86)=0.08, p=0.77, ICS concerns F(1,82)
=1.37, p=0.25 or the NCD F(1,82)=1.18, p=0.28.
No signiﬁcant change in reported adherence to ICS
between baseline and follow-up was found in either the
intervention group, z=0.63, p=0.53 or hospital care
group, z=0.16, p=0.87. Median MARS scores were similar
for both groups (intervention group: baseline
median=17.5, follow-up median=18.0; hospital care
group: baseline median=18.0, follow-up median=18.0. At
follow-up, 10/37 (27.0%) intervention patients were low
adherers relative to 9/46 (19.6%) hospital care patients,
χ2(1, n=83)=0.647, p=0.44. In the sensitivity analyses, the
same pattern (no change in adherence) was also seen
for participants who reported full adherence
(MARS=20) to participants who reported any non-
adherence (MARS<20).
Both groups reported high satisfaction with nurse spe-
cialists’ generic consultation skills and intervention-
speciﬁc consultation skills (MISS: intervention m=110.65,
SD=18.84, hospital care m=107.16, SD=16.95, t(110)
=1.03, p=0.31; MP5: intervention m=28.82 SD=5.41, hos-
pital care m=28.22, SD=5.33, t(107)=0.58, p=0.56).
Intervention premises
At baseline, low adherers had more doubts about their
need for ICS, more concerns about ICS medication and
a signiﬁcantly greater NCD score than high adherers
(p<0.05, table 4 and ﬁgure 3). The same pattern was
seen if participants who reported full adherence (n=33)
were compared with those who reported any non-
adherence (n=97). If continuous MARS scores were
used, higher baseline adherence scores were associated
with fewer ICS concerns in non-parametric correlations
(r(130)=−0.30, p<0.001), higher belief in personal need
for ICS (r(130)=0.28, p=0.001) and a greater NCD score
(r(130)=0.37, p<0.001). We assessed whether nurse spe-
cialists’ consultations changed postbrieﬁng for each step
(eliciting non-adherence using a ‘no-blame’ frame,
eliciting beliefs, addressing beliefs using a commonsense
rationale).
Nurse specialists asked an open question about adher-
ence in 0 hospital care consultations versus 14 (28.6%)
Table 2 Baseline demographic and clinical
characteristics
Hospital
care (n=63)
Intervention
(n=51)
Mean (SD) Mean (SD)
Age (years) 46.7 (17.2)* 47.8 (16.6)
Age left education (years) 19.5 (8.74)† 18.6 (8.43)‡
Age of asthma onset
(years)
23.7 (19.7)§ 22.1 (19.7)¶
n (%) n (%)
Female 44 (71.0)* 34 (66.7)
White 53 (85.5)* 43 (84.3)
Married 30 (49.2)¶ 26 (52.0)*
Employed FT/PT 30 (48.4)* 26 (52.0)*
Report comorbid illness 34 (54.8)* 21 (42.9)¶
Currently non-smoker 55 (90.2)¶ 45 (88.2)
Family history of asthma 36 (59.0)¶ 33 (66.0)*
*One participant missing data.
†Eight participants missing data.
‡Seven participants missing data.
§Three participants missing data.
¶Two participants missing data.
FT/PT, full time/part time.
Table 3 ICS beliefs at baseline and at 1 month follow-up
Baseline,
Mean (SD)
Follow-up,
Mean (SD)
Intervention group (n=38)
ICS necessity 3.89 (0.63) 4.04 (0.55) t(37)=2.25,
p=0.03
ICS concerns 2.54 (0.59) 2.40 (0.65) t(37)=2.22,
p=0.03
NCD 1.35 (0.92) 1.64 (0.90) t(37)=2.81,
p<0.01
Hospital care group (n=50)
ICS necessity 3.86 (0.72) 3.97 (0.68) t(49)=0.96,
p=0.34
ICS concerns* 2.35 (0.55) 2.31 (0.44) t(45)=0.70,
p=0.49
NCD* 1.57 (0.86) 1.71 (0.72) t(45)=1.84,
p=0.07
*n=46.
ICS, inhaled corticosteroids; NCD, Necessity-Concerns
Differential.
Table 4 Beliefs about ICS across high and low adherers
High
adherers
(n=88),
Mean (SD)
Low
adherers
(n=42),
Mean (SD)
ICS necessity 3.95 (0.53) 3.61 (0.73) t(128)=3.01,
p<0.01
ICS concerns 2.44 (0.55) 2.74 (0.55) t(128)=2.82,
p<0.01
ICS NCD 1.51 (0.87) 0.88 (0.93) t(128)=3.81,
p<0.001
ICS, inhaled corticosteroids; NCD, Necessity-Concerns
Differential.
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intervention consultations, χ2(1, n=108)=19.37, p<0.001,
demonstrating a signiﬁcant change in consultation style.
However, adherence was not elicited in this way in 35/49
(72.4%) consultations postbrieﬁng. Nurse specialists eli-
cited patients’ ICS beliefs more frequently after the
brieﬁng intervention. Beliefs about ICS necessity in the
absence of symptoms were elicited in 9 (18.4%) inter-
vention consultations versus 0 hospital care consulta-
tions, χ2(1, n=108)=11.63, p=0.001. ICS concerns were
elicited in 31 (63.3%) intervention consultations versus
1 (1.7%) hospital care consultations, χ2(1, n=108)
=48.67, p<0.001. Nurse specialists communicated the
necessity of taking ICS in the absence of symptoms in 18
(30.5%) hospital care consultations versus 21 (43.8%)
intervention consultations, χ2(1, n=107)=2.00, p=0.13.
Nurse specialists provided information to address
patients’ stated concerns about the potential adverse
consequences of ICS on 3 (5.1%) occasions prebrieﬁng
and 17 (34.7%) occasions postbrieﬁng, χ2(1, n=108)
=15.55, p<0.001. Despite this increase, in the majority
(32/49) of intervention consultations, ICS concerns
were not clearly addressed.
DISCUSSION
This feasibility study was part of an NCF intervention devel-
opment process, following MRC guidance.26 We tested the
feasibility of brieﬁng asthma nurse specialists to support
adherence by eliciting and addressing adherence-related
ICS necessity beliefs and concerns during hospital consul-
tations; examined process variables to evaluate why the
intervention did/did not work; indexed ﬁdelity of delivery;
and measured patient satisfaction. At follow-up, interven-
tion participants’ doubts about ICS necessity and concerns
decreased signiﬁcantly, indicating that adherence-related
beliefs are amenable to change. This change coincided
with an increase in the frequency with which nurse specia-
lists applied NCF components. This approach was not
used consistently, meaning that the intervention effect
across the groups was small.
As predicted, ICS necessity beliefs and concerns were
related to reported adherence, conﬁrming the premise
that addressing these might improve adherence and con-
sistency with NICE guidance8 22 and a recent
meta-analysis.11 We tested the premise that the brieﬁng
would change nurse specialists’ consultation behaviour.
Postbrieﬁng, nurse specialists used a ‘no-blame’ frame to
ask about adherence in 28.6% of consultations, elicited
doubts about the necessity of ICS in 18.6% of consulta-
tions, and elicited concerns about the adverse effects of
ICS in 63.3% of consultations. Prebrieﬁng, concerns were
elicited once, doubts about ICS necessity were not eli-
cited, and nor was an open, ‘no-blame’ question regard-
ing adherence used. Nurse specialists may need further
support to facilitate honest and open discussions of non-
adherence as recommended by NICE.22 However, despite
these postbrieﬁng changes, concerns about the adverse
effects and doubts about the need for ICS remained
unaddressed in most consultations. Discussing but not
addressing medication concerns and doubts may reduce
the efﬁcacy of the NCF approach. For example, providing
a rationale for ICS without eliciting necessity beliefs may
prevent appropriate tailoring of the rationale; therefore,
we may have demonstrated greater efﬁcacy if ﬁdelity of
intervention delivery been high.
In the intervention group, doubts about ICS necessity
and ICS concerns were reduced at 1 month after the
nurse consultation suggesting that after the brieﬁng,
nurse specialists were better able to reassure their
patients regarding their asthma treatment. The lack of
change in adherence is perhaps not surprising given the
high baseline adherence, risking a ceiling effect, and
the low ﬁdelity of intervention delivery achieved. We
assessed patients’ satisfaction with the consultations.
Satisfaction scores were high, prebrieﬁng and postbrief-
ing, for both generic skills measured by the MISS and
intervention-speciﬁc skills measured by the MP5, indicat-
ing that patients were typically very satisﬁed with the
nurse specialists’ consultations.
This was a feasibility study, and so was not designed or
powered to detect a change in intervention outcomes
relative to hospital care, explore heterogeneity across
sites or between nurses, or evaluate uncontrolled factors
(eg, increased experience of the nurse specialists, or
change in recruitment style after the brieﬁng resulting
in selection bias). We used self-report rather than more
objective adherence measures (eg, electronic monitor-
ing). We also relied on the nurses delivering the inter-
vention to recruit participants and hand out
Figure 3 Inhaled corticosteroids (ICS) necessity beliefs and
ICS concerns in patients with high and low adherence, at
baseline.
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questionnaires. It appears that as the demands of
running busy clinics were understandably prioritised
above collecting research data, this approach may have
resulted in a higher than anticipated level of missing
data (eg, for the completion of clinical assessment).
A large randomised controlled trial with speciﬁcally allo-
cated research assistance and additional adherence mea-
sures may resolve these limitations; however, further
intervention development is needed. Speciﬁcally, given
the possible ceiling effects, interventions should target
non-adherent patients or those whose ICS perceptions
indicate risk of non-adherence. New technologies for
supporting consultations in real time and structured
NCF scripts or aids may facilitate the identiﬁcation of
these patients, and increase ﬁdelity to the intervention.
Training nurse specialists more extensively, for example,
over more than two sessions, or changing the brieﬁng
content to include techniques such as motivational inter-
viewing, where patients are encouraged to explore
ambivalence to increase motivation,35 36 or cognitive
behavioural methods, for example, problem solving, cog-
nitive restructuring,37 may increase efﬁcacy.
This study conﬁrms the importance of eliciting and
addressing patients’ ICS necessity beliefs and concerns
in relation to non-adherence. The brieﬁng led to
increased necessity beliefs and reduced concerns, but
the NCF was not implemented consistently, so the
effects were small. The NCF intervention is promising,
but alternative methods, such as training for nurse spe-
cialists and new technologies, should be explored.
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